Literature DB >> 23264628

S-nitrosoglutathione induces ciliary neurotrophic factor expression in astrocytes, which has implications to protect the central nervous system under pathological conditions.

Manjeet K Paintlia1, Ajaib S Paintlia, Avtar K Singh, Inderjit Singh.   

Abstract

Accumulating evidence suggests that reactive astrogliosis has beneficial and detrimental outcomes in various CNS disorders, but the mechanism behind this dichotomy is unclear. Recent advances in this direction suggested that NO signaling is critical to regulate the outcomes of reactive astrogliosis in vivo. Using biochemical and genetic approaches, we here investigated the effect of S-nitrosoglutathione (GSNO; a physiological NO donor) in astrocytes in vitro settings. GSNO enhanced the expressions of glial fibrillary acidic protein and neurotrophic factors including ciliary neurotrophic factor (CNTF) in astrocytes in a dose-dependent manner. The enhanced CNTF expression in GSNO-treated astrocytes was ascribed to NO-mediated sGC/cGMP/PKG signaling. It was associated with p38 MAPK-dependent increased peroxisome proliferator-activated receptor-γ transactivation. In addition, the chromatin accessibility of peroxisome proliferator-activated receptor-γ accompanied with ATF2 and CREB (cAMP-response element-binding protein) was enhanced across the CNTF gene promoter in GSNO treated astrocytes. Interestingly, secreted CNTF was responsible for increased expression of glial fibrillary acidic protein in GSNO-treated astrocytes in an autocrine manner via a JAK2- and STAT3-dependent mechanism. In addition, CNTF secreted by GSNO-treated astrocytes enhanced the differentiation of immature oligodendrocytes in vitro. These effects of GSNO were consistent with an endogenously produced NO in astrocytes stimulated with proinflammatory cytokines in vitro. We conclude that NO signaling induces CNTF expression in astrocytes that favors the beneficial outcomes of reactive astrogliosis in vivo. Our data suggest that the endogenously produced NO or its exogenous source has potential to modulate the outcomes of reactive astrogliosis to protect CNS under pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264628      PMCID: PMC3567638          DOI: 10.1074/jbc.M112.405654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Characterization of ameboid microglia isolated from developing mammalian brain.

Authors:  D Giulian; T J Baker
Journal:  J Neurosci       Date:  1986-08       Impact factor: 6.167

2.  Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.

Authors:  W P Arnold; C K Mittal; S Katsuki; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

Review 3.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

4.  Nitric oxide modulation of human leukemia cell differentiation and gene expression.

Authors:  G Magrinat; S N Mason; P J Shami; J B Weinberg
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

5.  A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

Authors:  S A Lipton; Y B Choi; Z H Pan; S Z Lei; H S Chen; N J Sucher; J Loscalzo; D J Singel; J S Stamler
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

6.  CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death.

Authors:  J C Louis; E Magal; S Takayama; S Varon
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

7.  Astrogliosis in culture: I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis.

Authors:  A C Yu; Y L Lee; L F Eng
Journal:  J Neurosci Res       Date:  1993-02-15       Impact factor: 4.164

8.  Ciliary neurotrophic factor induces type-2 astrocyte differentiation in culture.

Authors:  S M Hughes; L E Lillien; M C Raff; H Rohrer; M Sendtner
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

Review 9.  Nitric oxide: a new messenger in the brain.

Authors:  J Bruhwyler; E Chleide; J F Liégeois; F Carreer
Journal:  Neurosci Biobehav Rev       Date:  1993       Impact factor: 8.989

10.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  20 in total

1.  Mechanisms Involved in the Remyelinating Effect of Sildenafil.

Authors:  Daniela Díaz-Lucena; María Gutierrez-Mecinas; Beatriz Moreno; José Lupicinio Martínez-Sánchez; Paula Pifarré; Agustina García
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-03       Impact factor: 4.147

2.  Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.

Authors:  Ajaib S Paintlia; Manjeet K Paintlia; Avtar K Singh; Inderjit Singh
Journal:  Glia       Date:  2013-07-10       Impact factor: 7.452

3.  S-Nitrosoglutathione ameliorates acute renal dysfunction in a rat model of lipopolysaccharide-induced sepsis.

Authors:  Devadoss J Samuvel; Anandakumar Shunmugavel; Avtar K Singh; Inderjit Singh; Mushfiquddin Khan
Journal:  J Pharm Pharmacol       Date:  2016-08-03       Impact factor: 3.765

Review 4.  The contribution of astrocytes and microglia to traumatic brain injury.

Authors:  Ila P Karve; Juliet M Taylor; Peter J Crack
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 5.  Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.

Authors:  José Iglesias; Ludis Morales; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.590

6.  A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination.

Authors:  Yuan Zhang; Xing Li; Bogoljub Ciric; Mark T Curtis; Wan-Jun Chen; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-06       Impact factor: 11.205

7.  Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery.

Authors:  Mouna Lagraoui; Gauthaman Sukumar; Joseph R Latoche; Sean K Maynard; Clifton L Dalgard; Brian C Schaefer
Journal:  Brain Behav Immun       Date:  2016-12-07       Impact factor: 7.217

8.  Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.

Authors:  Ajaib S Paintlia; Sarumathi Mohan; Inderjit Singh
Journal:  J Clin Cell Immunol       Date:  2013-06-30

9.  AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model.

Authors:  Ajaib S Paintlia; Manjeet K Paintlia; Sarumathi Mohan; Avtar K Singh; Inderjit Singh
Journal:  Am J Pathol       Date:  2013-06-10       Impact factor: 4.307

Review 10.  Traumatic Brain Injury: Ultrastructural Features in Neuronal Ferroptosis, Glial Cell Activation and Polarization, and Blood-Brain Barrier Breakdown.

Authors:  Delong Qin; Junmin Wang; Anh Le; Tom J Wang; Xuemei Chen; Jian Wang
Journal:  Cells       Date:  2021-04-24       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.